Paveway PLUS™ – Enabling Faster, Better Decisions in Early Stage Development of Microbial Based Biotherapeutics

Home | Knowledge Center | Resource Library | Paveway PLUS™ – Enabling Faster, Better Decisions in Early Stage Development of Microbial Based Biotherapeutics

Steve Loftus, PhD, Microbial Business Steering Group Lead at FUJIFILM Biotechnologies, describes the benefits of microbial fermentation for biologics production, and the recent improvements introduced to the Paveway microbial expression platform.

Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy